Encompass Health director awarded 17 dividend RSUs

Encompass Health Corp director Kevin J. O’Connor reported a small compensation-related equity award.

Rhea-AI Filing Summary

Encompass Health Corp director Kevin J. O’Connor reported a small compensation-related equity award. On April 15, 2026, he acquired 17 Encompass Health common stock restricted stock units credited in connection with a common stock dividend. These units were valued using the $105.24 closing price on the dividend payment date. Following this award, his directly held Encompass Health common stock position stands at 9,929 shares.

Insider Trade Summary

Grant/Award: 17 shares

Grant/Award 1 txn

Insider O'Connor Kevin J.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Encompass Health Common Stock	17	$0.00	$0.00

Holdings After Transaction: Encompass Health Common Stock — 9,929 shares (Direct)

Footnotes (1)

1. F1. Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $105.24. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

Key Figures

RSUs awarded: 17 units Shares held after transaction: 9,929 shares Dividend per share: $0.19 per share +1 more

4 metrics

RSUs awarded 17 units Dividend-related RSU credit on April 15, 2026

Shares held after transaction 9,929 shares Direct Encompass Health common stock position after RSU award

Dividend per share $0.19 per share Encompass Health common stock dividend paid April 15, 2026

Closing stock price $105.24 Encompass Health closing price on April 15, 2026 used to calculate RSUs

Key Terms

restricted stock units, dividend record date, dividend payment date, common stock dividend, +1 more

5 terms

restricted stock units financial

"additional restricted stock units ("RSUs") are credited to each non-employee director's account"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

dividend record date financial

"the number of the RSUs in each director's account on the associated dividend record date"

dividend payment date financial

"the closing price on the dividend payment date"

common stock dividend financial

"Encompass Health paid a dividend on its common stock of $0.19 per share"

Form 4 regulatory

"The transaction reported on this Form 4 is an award of RSUs"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Encompass Health (EHC) director Kevin J. O’Connor report on this Form 4?

Kevin J. O’Connor reported receiving 17 restricted stock units tied to Encompass Health common stock. These units were credited as additional director compensation in connection with a regular common stock dividend paid on April 15, 2026.

How many Encompass Health (EHC) shares does Kevin J. O’Connor hold after this transaction?

After the April 15, 2026 award, Kevin J. O’Connor directly holds 9,929 shares of Encompass Health common stock. This figure reflects his total direct position following the crediting of 17 dividend-related restricted stock units.

What triggered the 17 restricted stock units granted to the Encompass Health (EHC) director?

The 17 restricted stock units were triggered by Encompass Health’s cash dividend on its common stock. Under existing director RSU award agreements, additional units are credited whenever a dividend is paid, based on the per-share dividend and the stock’s closing price.

How were the additional Encompass Health (EHC) restricted stock units calculated for Kevin J. O’Connor?

Additional RSUs are calculated by multiplying existing RSUs by the per-share dividend, then dividing by the stock’s closing price. On April 15, 2026, Encompass Health paid a $0.19 per-share dividend and the closing price was $105.24, resulting in 17 new RSUs for O’Connor.

Did Kevin J. O’Connor pay cash to acquire the Encompass Health (EHC) shares reported on this Form 4?

No cash was paid for these 17 Encompass Health restricted stock units. They were credited automatically under existing director RSU agreements as a stock-based adjustment related to the company’s April 15, 2026 common stock dividend.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/16/2026 - 02:43 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

O'Connor Kevin J.

(Last) (First) (Middle)

9001 LIBERTY PARKWAY

(Street)

BIRMINGHAM ALABAMA 35242

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Encompass Health Common Stock	04/15/2026		A		17(1)	A	$0	9,929	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $105.24. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

	/s/ Patrick Darby, attorney-in-fact for Kevin J. O'Connor	04/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)